WST West Pharmaceutical Services, Inc.
WST West Pharmaceutical Services, Inc.
Healthcare · Medical Instruments & Supplies
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $274.59 · VWAP $294.20 · +30.5% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
WST Price Structure
Loading timeframes…
Peers
Every watchlist WST belongs to, members best 30-day change first — WST highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@trace-glp1-manufacturing
Reported the quarter ending 2026-06-30: revenue $872M, diluted EPS $2.15, net income $154M (SEC filing). Across the print the stock moved -8.4% (close before → first close after).
full note →Against street estimates
How WST's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about WST from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 4 days ago · Oct 13
- West Reports Second-Quarter 2026 Results - PR Newswire
- West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Highlights: Strong Organic Growth ...
- West Pharmaceutical Services (WST) Q2 2026 Earnings Results ...
- West Pharmaceutical Services stock hits 52-week high at 363.38 USD By Investing.com
- West Pharmaceutical Services Inc (WST) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
WST research tape
50 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.